Company news, press releases, and more. Follow this page for new exciting updates and more news on what is happening at CELLINK.
As part of BICO’s mission to reduce the impact due to organ shortages, CELLINK a part of BICO Bioprinting will now be able to provide
Addressing the gaps of organ shortages with a novel platform for the personalization of xenogeneic and 3D printed tissue scaffolds – an enormous opportunity for
The BIO CELLX is a first of its kind biodispensing platform used to automate 3D cell culture. By providing cell biologists with pre-validated protocols, the
CollPlant and CELLINK will explore the use of CELLINK’s next-generation high throughput extrusion bioprinters for the future commercial production of CollPlant’s regenerative breast implants, addressing
The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-its-kind bioprinter Today, BICO companies CELLINK and Nanoscribe
The breakthrough was achieved by CELLINK’s longtime customer CTIBIOTECH and the NOVOPLASM Research Consortium by leveraging 3D bioprinted skin and cold plasma wound healing treatment
CELLINK’s vision and dream is to be able to contribute to the future of medicine by addressing some of the key challenges in modern healthcare.
We’re excited to share that we’ve been granted two patents relating to the regulation and precise control of bioinks’ processing temperatures in CELLINK’s 3D Bioprinters.
The three companies have joined forces to present customers a first of its kind full-service 3D biomanufacturing and in vitro analysis service. Today, BICO subsidiaries
CELLINK Group has been awarded 3 prestigious awards by the iF Design Awards 2021 for design excellence. With these achievements, CELLINK is now in the
Avijit Minocha
Head of Marketing
akm@bico.com
Send us an email by filling in the contact form here.
U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284
